Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods

View ORCID ProfileRachel Y. Oh, View ORCID ProfileAli AlMail, View ORCID ProfileDavid Cheerie, George Guirguis, Huayun Hou, Kyoko E. Yuki, View ORCID ProfileBushra Haque, Bhooma Thiruvahindrapuram, Christian R. Marshall, Roberto Mendoza-Londono, Adam Shlien, Lianna G Kyriakopoulou, Susan Walker, James J. Dowling, Michael D. Wilson, View ORCID ProfileGregory Costain
doi: https://doi.org/10.1101/2023.06.29.23292012
Rachel Y. Oh
1Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Canada
2Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel Y. Oh
Ali AlMail
2Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ali AlMail
David Cheerie
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Cheerie
George Guirguis
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huayun Hou
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyoko E. Yuki
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
5Division of Genome Diagnostics, Hospital for Sick Children, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bushra Haque
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bushra Haque
Bhooma Thiruvahindrapuram
6The Centre for Applied Genomics, SickKids Research Institute, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian R. Marshall
5Division of Genome Diagnostics, Hospital for Sick Children, Toronto, Canada
7Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Mendoza-Londono
1Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Canada
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
8Department of Paediatrics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Shlien
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
5Division of Genome Diagnostics, Hospital for Sick Children, Toronto, Canada
7Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lianna G Kyriakopoulou
5Division of Genome Diagnostics, Hospital for Sick Children, Toronto, Canada
7Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Walker
6The Centre for Applied Genomics, SickKids Research Institute, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James J. Dowling
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
8Department of Paediatrics, University of Toronto, Toronto, Canada
9Division of Neurology, Hospital for Sick Children, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Wilson
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Costain
1Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Canada
3Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
8Department of Paediatrics, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gregory Costain
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background/Objectives Canonical splice site variants (CSSVs) are often presumed to cause loss-of-function (LoF) and are assigned very strong evidence of pathogenicity (according to ACMG criterion PVS1). However, the exact nature and predictability of splicing effects of unselected rare CSSVs in blood-expressed genes is poorly understood.

Methods A total of 184 rare CSSVs in unselected blood-expressed genes were identified by genome sequencing in 121 individuals, and their impact on splicing was interrogated manually in RNA sequencing (RNA-seq) data. Blind to these RNA-seq data, we attempted to predict the precise impact of CSSVs by applying in silico tools and the ClinGen Sequence Variant Interpretation Working Group 2018 guidelines for applying PVS1 criterion.

Results There was no evidence of a frameshift nor of reduced expression consistent with nonsense-mediated decay (NMD) for 24% of CSSVs: 17% had wildtype splicing only and normal junction depths, 3.25% resulted in cryptic splice site usage and in-frame indels, 3.25% resulted in full exon skipping (in-frame), and 0.5% resulted in full intron inclusion (in-frame). Misclassification rates for splicing outcome (frameshift/NMD vs. no frameshift/no NMD) using (i) SpliceAI, (ii) MaxEntScan, and (iii) AutoPVS1 ranged from 30-41%, with none outperforming a simple “zero rule” classifier.

Conclusion Nearly 1 in 4 CSSVs may not cause LoF based on analysis of RNA-seq data. Predictions from in silico methods were often discordant with findings from RNA-seq. More caution may be warranted in applying PVS1-level evidence to CSSVs in the absence of functional data.

Competing Interest Statement

S.W. is currently an employee of Genomics England Limited. The other authors declare no competing interests.

Funding Statement

Funding was provided by Genome Canada (OGI-158; M.D.W., A.S., and J.J.D.), the SickKids Centre for Genetic Medicine and Translational Genomics Node, the Sickkids Research Institute, the Canadian Institutes of Health Research (Funding Reference Number: PJT186240), and the University of Toronto McLaughlin Centre.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of The Hospital for Sick Children gave ethical approval for the two genome sequencing and RNA-seq studies included in this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Genome sequencing, RNA-seq analysis, and in silico prediction data will be shared upon request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods
Rachel Y. Oh, Ali AlMail, David Cheerie, George Guirguis, Huayun Hou, Kyoko E. Yuki, Bushra Haque, Bhooma Thiruvahindrapuram, Christian R. Marshall, Roberto Mendoza-Londono, Adam Shlien, Lianna G Kyriakopoulou, Susan Walker, James J. Dowling, Michael D. Wilson, Gregory Costain
medRxiv 2023.06.29.23292012; doi: https://doi.org/10.1101/2023.06.29.23292012
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods
Rachel Y. Oh, Ali AlMail, David Cheerie, George Guirguis, Huayun Hou, Kyoko E. Yuki, Bushra Haque, Bhooma Thiruvahindrapuram, Christian R. Marshall, Roberto Mendoza-Londono, Adam Shlien, Lianna G Kyriakopoulou, Susan Walker, James J. Dowling, Michael D. Wilson, Gregory Costain
medRxiv 2023.06.29.23292012; doi: https://doi.org/10.1101/2023.06.29.23292012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14638)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)